Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Testing effectiveness (Phase 2)Ended earlyNCT03531827
What this trial is testing

Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Who this might be right for
Metastatic Castration Resistant Prostate CancerProstate Neoplasms
National Cancer Institute (NCI) 4
Large-scale testing (Phase 3)Looking for participantsNCT07481786
What this trial is testing

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Who this might be right for
Lung AdenocarcinomaBrain MetastasesRadiotherapy, Intensity-Modulated+2 more
Sun Yat-sen University 220
Early research (Phase 1)Study completedNCT00217373
What this trial is testing

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 33
Not applicableLooking for participantsNCT05474573
What this trial is testing

Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases

Who this might be right for
Glioma, MalignantMetastases to Brain
Sklifosovsky Institute of Emergency Care 52
Testing effectiveness (Phase 2)Study completedNCT00274469
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 205
Early research (Phase 1)Looking for participantsNCT06067841
What this trial is testing

Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Bristol-Myers Squibb 140
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Not applicableAvailableNCT06761976
What this trial is testing

Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation

Who this might be right for
Advanced Non-small Cell Lung CancerCancer
Bayer
Early research (Phase 1)UnknownNCT05643417
What this trial is testing

Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy

Who this might be right for
Metastatic Liver Cancer
Fudan University 80
Testing effectiveness (Phase 2)Study completedNCT00322517
What this trial is testing

Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 90
Not applicableStudy completedNCT05005650
What this trial is testing

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy

Who this might be right for
Ovarian Cancer Stage IVLymph Node Metastases
Seoul National University Hospital 121
Testing effectiveness (Phase 2)Looking for participantsNCT06480110
What this trial is testing

Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)Ended earlyNCT05583110
What this trial is testing

Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerLocally Advanced HER2 Positive Breast Carcinoma
Spanish Breast Cancer Research Group 13
Testing effectiveness (Phase 2)Ended earlyNCT01499160
What this trial is testing

Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsEndocrine Breast DiseasesNeoplasm Metastasis
University of Maryland, Baltimore 7
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Looking for participantsNCT06568562
What this trial is testing

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Utah 32
Early research (Phase 1)Study completedNCT00207103
What this trial is testing

MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
TumorsNeoplasm Metastasis
Bristol-Myers Squibb 68
Early research (Phase 1)Looking for participantsNCT06640413
What this trial is testing

Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors

Who this might be right for
FAP
Philogen S.p.A. 56
Not applicableUnknownNCT00899613
What this trial is testing

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
University Hospital, Caen 270
Next Page